Advisory Committee
Cancer researchers form closer link to ‘real world’ via rural advisory board
The University of Colorado has launched a volunteer community advisory board designed to provide feedback to cancer researchers on making studies more accessible and relevant to rural populations.
FDA panel denies biologic license application for ALS stem cell therapy
The FDA’s Cellular, Tissue and Gene Therapies Advisory Committee has voted to deny a biologics license application for NurOwn, an investigational mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis.
Q&A: Respiratory therapist discusses RSV vaccines, CDC recommendation
At this point in 2023, several advances have been made to protect individuals from respiratory syncytial virus.
CDC advisors give nod to 20-valent pneumococcal vaccine for children
CDC advisors on Thursday unanimously supported the addition of Pfizer’s 20-valent pneumococcal vaccine as an option for children in the United States.
CDC advisors recommend older adults consider RSV vaccination
CDC vaccine advisors said Wednesday that older adults in the United States should talk to their physicians about getting vaccinated against respiratory syncytial virus.
FDA advisors say new COVID-19 vaccines should be monovalent, targeting XBB
An FDA advisory committee voted Thursday to recommend changing the composition of the country’s COVID-19 vaccines to be monovalent XBB-lineage vaccines, removing the wild strain of SARS-CoV-2 from the shots.
FDA advisors recommend monoclonal antibody to protect infants from RSV
An FDA advisory committee on Thursday voted in favor of approving the long-acting monoclonal antibody nirsevimab to protect neonates and infants from respiratory syncytial virus.
Intercept ‘disappointed’ after FDA setback for top NASH contender; stock drops 16%
Intercept Pharmaceuticals saw a 16% drop in its stock value after an FDA advisory committee declined to approve obeticholic acid in pre-cirrhotic patients with liver fibrosis due to nonalcoholic steatohepatitis.
FDA advisory committee votes in support of epinephrine nasal spray for anaphylaxis
The U.S. FDA Pulmonary-Allergy Drug Advisory Committee said available data support a favorable benefit-risk assessment for ARS Pharmaceuticals’ neffy nasal spray in treating anaphylaxis in adults and in children who weigh at least 30 kg.
FDA advisory committee did not recommend de novo classification for meniscus implant
The Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee of the FDA did not recommend de novo classification for an artificial meniscus implant.